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Background. Heart failure (HF) is associated with cardiac autonomic denervation (AD),
which can be non-invasively assessed by 123I-metaiodobenzylguanidine (123I-mIBG) scintigra-
phy and has prognostic implications. We aimed to study the relationship between myocardial
contractility assessed by global longitudinal strain (GLS) and AD assessed by 123I-mIBG
scintigraphy in advanced HF.
Methods/Results. BETTER-HF is a prospective randomized clinical trial including HF
patients (pts) submitted to cardiac resynchronization therapy (CRT) who are submitted to a
clinical, echocardiographic, and scintigraphic assessment before and 6 months after CRT. 81
pts were included. An echocardiographic response (absolute increase in left ventricular ejection
fraction ‡ 10%) was observed in 73.7% of pts. A higher baseline late heart-to-mediastinum
ratio (HMR) was associated with a better echocardiographic response. There was a significant
association between late HMR and GLS at baseline and 6 months. At baseline, GLS had an
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AUC of 0.715 for discrimination for a late HMR < 1.6. A GLS cut-off of 2 9% maximized the
likelihood of correctly classifying a pt as having severe AD (HMR < 1.6).
Conclusion. Myocardial contractility as assessed by GLS is moderately correlated with AD
as assessed by 123I-mIBG scintigraphy and has a good discrimination for the identification of
severe cardiac denervation. GLS may allow for a more readily accessible estimation of the
degree of AD in advanced HF pts. (J Nucl Cardiol 2017)




CRT Cardiac resynchronization therapy
GLS Global longitudinal strain
HMR Heart-to-mediastinum ratio
HFrEF Heart failure with reduced ejection
fraction
ICC Intraclass correlation coefficient
LVEF Left ventricular ejection fraction
WR Washout rate
INTRODUCTION
Heart failure (HF) is a very prevalent clinical entity,
affecting 1-12% of the adult population in developed
countries1 and C 10% among individuals older than
70 years.2 Despite recent improvements in treatments
and their implementation in patients (pts) with HF with
reduced ejection fraction (HFrEF), the mortality and
hospitalization rate have remained high.3
Sympathetic nervous system overactivity is a hall-
mark of HF4 and is initially beneficial as it intends to
preserve cardiac output and other hemodynamic param-
eters. However, chronically elevated catecholamine
levels dampen cardiovascular reflexes and downregulate
adrenergic nerve terminals in the myocardium, thus
promoting the desensitization of the heart to sympathetic
stimulation.5 This cardiac denervation contributes
directly to disease progression and is related to a worse
outcome.6
123I-metaiodobenzylguanidine (123I-mIBG) cardiac
scintigraphy is an imaging method that uses a radioac-
tive tracer, 123I-mIBG, which binds to cardiac
presynaptic adrenergic receptors and is not affected by
intracellular metabolism thus permitting an in vivo
assessment of cardiac autonomic innervation.7 It is a
safe method8 that has been demonstrated to predict
mortality and cardiac events independently of other
prognostic markers,9–11 stratify the risk of sudden
cardiac death and ventricular arrhythmias12–14, and
assess response to medical15–18 and device therapy.19–23
It has been proposed to aid in the clinical management
and assessment of prognosis of HF pts, but the fact that
it is not easily accessible and the need for radiation
exposure precludes its widespread use.
Quantification of the left ventricular ejection frac-
tion (LVEF) by the modified biplane Simpson’s rule has
been historically used to stratify pts into the two
categories of HF: preserved and reduced ejection frac-
tion.24 Recently, other parameters to determine left
ventricular function have been developed. Global lon-
gitudinal strain (GLS) as assessed by speckle tracking
measures left ventricular wall deformation and has
proven to have added prognostic value over LVEF in the
setting of HF.25,26
To overcome the shortcomings of 123I-mIBG
scintigraphy, we hypothesized that myocardial contrac-
tility would reflect local autonomic denervation (AD)
and as such, would allow for estimation of cardiac
autonomic dysfunction. Our aim was to study the
relationship between myocardial contractility as
assessed by GLS and autonomic dysfunction as assessed
by 123I-mIBG scintigraphy in pts with HFrEF.
METHODS
Study Design
BETTER-HF (NCT02413151) is a prospective, interven-
tional, randomized, single center clinical trial of the effect of
prolonged cardiac rehabilitation on autonomic function and
clinical and echocardiographic response of pts with HFrEF
submitted to cardiac resynchronization therapy (CRT).
One hundred and twenty-one adult ([ 18 years) HFrEF
pts referred for CRT were prospectively enrolled between
April 2011 and February 2015. Pts were subjected to a baseline
assessment before CRT, including clinical evaluation, blood
analysis, and transthoracic echocardiogram and were reeval-
uated at 6 months after CRT. 123I-mIBG scintigraphy was
performed in all pts at baseline. Of these, 81 had baseline GLS
measurement as part of the echocardiographic assessment.
When feasible due to distance and cost of transportation, pts
were submitted to 123I-mIBG scintigraphy reevaluation at
6 months after enrollment (N = 55). Of these, 40 pts had GLS
measurement at 6 months.
All pts signed a written informed consent form before the
performance of any procedure. The study was approved by the
Institutional Review Board and Ethics Committee.
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Echocardiographic Acquisition and
Processing
A GE Vivid 9 ultrasound system was used to acquire
parasternal long- and short-axis views, as well as apical two-,
three-, and four-chamber views. Echocardiographic parameters
were determined according to the American Society of
Echocardiography’s recommendations.24,27 Left atrial volume
was assessed by the biplane method of disks. LVEF was
measured using the biplane Simpson’s method. Estimation of
GLS was performed offline following acquisition of apical
two-, three-, and four-chamber views, using a semi-automatic
algorithm in the EchoPAC BT12 software, based on regional
assessment of 18 segments, the mean of which was used to
calculate GLS. The variability of GLS measurement in HFrEF
pts has previously been assessed, showing good intra- and
inter-observer reproducibility of this measurement.28
123I-mIBG Cardiac Scintigraphy Acquisition
and Processing
123I-mIBG scintigraphy was performed by obtaining
planar images in an anterior projection using a single-headed
Siemens e.Cam camera fitted with a low-energy high-resolu-
tion collimator. Counts were acquired for 240 seconds into a
128 9 128 pixel matrix 15 minutes (early) and 4 hours (late)
after the intravenous injection of 185 MBq of 123I-mIBG. The
main energy window was centered to 15% of the 159-keV 123I
photopeak. No scatter correction was applied. Thyroid block-
ade with potassium iodide was performed[ 30 minutes before
123I-mIBG injection. Cardiovascular drugs, namely b-blockers,
were maintained at both acquisitions. Antidepressants were
interrupted, whenever possible, not to cause any interference.
Images were processed on a WS Siemens Syngo workstation.
Early and late heart-to-mediastinum ratio (HMR) were
calculated after measuring the mean count of 123I-mIBG
uptake per pixel in two separate visually drawn regions of
interest: around the entire heart (H) and over the midline upper
mediastinum to reflect the location with lowest activity (M).
The washout rate (WR) was expressed as a percentage and
calculated according to this formula:
ððEarly Mearly HÞ  ðlate Mlate HÞÞ=ðearly Mearly HÞ  100:
In order to confirm reproducibility of this imaging
technique, all the scans were evaluated by two separate readers
with the average value for each parameter taken for the main
analysis.
Definitions
Echocardiographic response to CRT was defined as an
absolute increase in LVEF of C 10%.29 Severe cardiac den-
ervation was defined as a late HMR\ 1.6.
Statistical Analysis
Continuous variables were expressed as mean and stan-
dard deviation when they followed a normal distribution, and
as median and interquartile range otherwise. Qualitative
variables were expressed as frequency and percentage. Com-
parison between continuous variables was performed with the
non-parametric Wilcoxon signed-rank test and between qual-
itative variables with the v2 test. Inter-rater agreement of 123I-
mIBG scintigraphy was evaluated by the intraclass correlation
coefficient (ICC). Intra-observer variability was not assessed in
this population since the interpretation of the exam was only
performed once by each reader. However, the intra-observer
agreement regarding this imaging modality is known to be
high in HF pts.30 We employed logistic regression analysis to
assess the impact of cardiac denervation as assessed by 123I-
mIBG scintigraphy on echocardiographic response to CRT as
defined above (LVEF variation C 10%). In addition, we tested
for the interaction of baseline LVEF to control for its effect on
response to CRT. The relation between scintigraphic and
echocardiographic variables and AD at baseline and 6 months
was explored with the use of the Pearson correlation coeffi-
cient. A subanalysis was performed to assess for a more
significant correlation in the following pre-specified sub-
groups: LVEF\ 25%, female gender, ischemic etiology, and
age[ 70 years. To analyze the discrimination of GLS for the
detection of severe cardiac AD we performed a receiving-
operator curve analysis for a pre-specified late heart-to-
mediastinum cut-off value of 1.6. The optimum cut-off value
for GLS was determined using the maximum likelihood ratio.
A P value\ 0.05 was considered statistically significant. All




A total of 81 pts had available data on pre-
implantation 123I-mIBG scintigraphy and GLS and were
included in this study. All pts were submitted to CRT as
previously described. Mean age was 69.4 years (range
35-84 years). Pt characteristics are displayed in Table 1.
Planar Heart-to-Mediastinum Ratio
Mean HMR and WR were obtained for all pts on
both early and late imaging for baseline assessment, and
for a subset of 40 pts at 6 months follow-up. ICC for
early HMR was 0.767 (95% CI 0.686-0.827, P\ 0.001)
and for late HMR 0.729 (95% CI 0.632-0.797,
P\ 0.001). The results for measurements of early
HMR, late HMR, and WR are presented on Table 2.
No significant difference was found between cardiac
denervation at baseline and at 6 months follow-up
(Wilcoxon signed-rank test, P = NS). Regarding the
association between baseline 123I-mIBG parameters and
CRT response, late HMR was the only scintigraphic
parameter that predicted CRT response at 6 months
(Figure 1, OR 11.6, 95% CI 1.17-114, P = 0.036); this
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result was independent of LVEF (P for interac-
tion = NS). 54.3% of the pts with late HMR\ 1.6
showed an echocardiographic response. No significant
association was found between early HMR or WR and
CRT response (P = NS for both).
Echocardiographic Measurements
Echocardiographic measurements are described in
Table 3. Mean LVEF at baseline was 26.3%, with an
increase C 10% noted during follow-up in 46 pts
(56.8%). We observed a significant improvement during
the study period regarding LVEF, left ventricular end-
systolic volume, mean E/e0 ratio, and GLS (P B 0.05 for
all).
Correlation Between Echocardiographic
Parameters and Cardiac Denervation
Conventional echocardiographic measures includ-
ing LVEF, E/A ratio, E/e0 ratio, and tricuspid annular
plane systolic excursion were not significantly correlated
with any scintigraphic measures of cardiac denervation
(P = NS for all). There was a significant association
between late HMR and GLS, both at baseline (Coeff: R
- 0.282, P = 0.01, Figure 2A) and at 6 months (Coeff:
R - 0.363, P = 0.021, Figure 2B). No significant cor-
relation was found between GLS and early HMR or WR
(Table 4).
To investigate whether GLS could be more useful in
assessing cardiac denervation in specific subsets of pts,
we additionally performed correlation analysis for pre-
specified subgroups. Performance of GLS in predicting
Table 1. Baseline characteristics
Total population N 5 81
Repeat imaging group
N 5 40
Age (years) 68.10 ± 12.94 65.81 ± 11.50
Male gender 55 (67.5) 31 (75.5)
Etiology
Ischemic cardiomyopathy 23 (28.75) 14 (35.0)
Dilated cardiomyopathy 54 (67.5) 24 (5.0)
Valvular heart disease 3 (3.75) 2 (60.0)
NYHA functional class
II 22 (25.75) 6 (15.0)
III 56 (70.0) 32 (80.0)
IV 2 (2.5) 2 (5.0)
Current smoking 14 (16.9) 5 (12.8)
Diabetes mellitus 35 (43.1) 18 (46.2)
Hypertension 70 (86.2) 34 (87.2)
Dyslipidemia 54 (67.2) 30 (76.9)
Obesity 24 (29.7) 10 (25.6)
Medication
b-Blocker 71 (87.7) 35 (89.7)
ACEi or ARB 74 (90.9) 36 (92.3)
Diuretics 76 (93.8) 36 (92.3)
BNP (pgmL) 574.78 ± 604.49 482.46 ± 411.95
No significant differences were seen between the two groups
ACEi, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; BNP, brain natriuretic peptides; NYHA, New
York Heart Association
Table 2. Early and late heart-to-mediastinum









Early HMR 1.53 ± 0.15 1.50 ± 0.16 0.07
Late HMR 1.43 ± 0.18 1.46 ± 0.15 0.33
Washout
rate
45.68 ± 24.01 40.53 ± 20.29 0.71
FU, follow-up; HMR, heart-to-mediastinum ratio; SD, standard
deviation
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cardiac denervation was better in pts with LVEF\ 25%
(Coeff: R - 0.405, P = 0.019), ischemic etiology (Co-
eff: R - 0.413, P = 0.050) and female gender (Coeff: R
- 0.426, P = 0.026); age did not affect the association
between GLS and late HMR.
Regarding the discrimination of GLS for the pre-
specified cut-off value of late HMR for cardiac denerva-
tion, GLS had an area under the curve of 0.721 (bootstrap)
for discrimination of a late HMR\ 1.6 on the baseline
assessment (Figure 3). A GLS cut-off value of—9%
maximized the likelihood of correctly classifying a pt as
having severe cardiac denervation (likelihood ratio 2.83).
DISCUSSION
In our study we assessed the relationship between
cardiac denervation as assessed by 123I-mIBG cardiac
scintigraphy and global cardiac deformation in advanced
systolic HF pts submitted to CRT. The main findings of
our study were: (1) cardiac denervation was prevalent in
this high-risk population; (2) cardiac denervation pre-
dicted echocardiographic response at 6 months
independently of LVEF; and (3) a significant correlation
between the cardiac denervation and GLS at baseline



























No echocardiographic response Echocardiographic response
Figure 1. Association between late heart-to-mediastinum ratio and echocardiographic response.
Echocardiographic response to cardiac resynchronization therapy (CRT) was defined as an absolute
increase in left ventricular ejection fraction of C 10%. Late heart-to-mediastinum ratio (HMR) was
the only baseline scintigraphic parameter that predicted CRT response at 6 months (OR 11.6, 95% CI
1.17-114, P 0.036), with patients with no echocardiographic response having a lower late HMR at
baseline (1.35 vs 1.44).





N 5 81 P values
LVEF (%) 26.27 ± 7.09 38.48 ± 11.05 \0.001
LVEDV (mL) 207.7 ± 63.8 203.0 ± 74.9 0.245
LVESV (mL) 159.2 ± 51.8 142.9 ± 62.5 \0.001
Mean E/e0 ratio 18.15 ± 11.17 14.93 ± 8.28 0.050
Left atrial volume (mL) 85.3 ± 46.2 80.2 ± 51.3 0.210
Global longitudinal strain - 6.28 ± 3.28 - 8.20 ± 3.74 0.002
TAPSE (mm) 19.49 ± 6.01 19.64 ± 5.39 0.668
SPAP (mmHg) 40.6 ± 12.5 38.1 ± 11.2 0.064
FU, follow-up; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVESV, left ventricular end-
systolic volume; SPAP, systolic pulmonary artery pressure; TAPSE, tricuspid annular plane systolic excursion
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Cardiac Denervation in Advanced Systolic
Heart Failure
HF is characterized by changes in myocardial
sympathetic activity, which serves initially as a favor-
able compensatory mechanisms but ultimately leads to
deleterious neurohormonal and myocardial structural
alterations and increase the likelihood of arrhythmias or
cardiac death.31
Previous studies have assessed the prevalence of
cardiac denervation in advanced HF.12,32 Multiple
methodologies may be employed in the estimation of
degree of cardiac denervation, either evaluating global



























































Figure 2. Correlation between late heart-to-mediastinum ratio and global longitudinal strain at
baseline (A) and at 6-month follow-up (B). (A) A significant correlation between late heart-to-
mediastinum ratio and global longitudinal strain at baseline was seen using the Pearson’s correlation
coefficient (R - 0.282, P 0.010). (B) A significant correlation between late heart-to-mediastinum
ratio and global longitudinal strain at 6 months was seen using the Pearson’s correlation coefficient
(R - 0.363, P 0.021).
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or single photon emission computed tomography
(SPECT)-derived regional measures such as the defect
score.13 Of note, all have been correlated to non-
invasive measures of autonomic activity.33,34
The inter-observer agreement of HMR in our
population, as measured by the ICC, indicated good to
excellent reproducibility.35
Prognostic Value of 123I-mIBG Scintigraphy
in Advanced Heart Failure
There are several studies linking cardiac autonomic
function to prognosis in advanced systolic HF pts;
extensive data report on the association between mea-
sures of cardiac denervation and arrhythmic events in
ICD recipients.12,13,36,37 In addition, the landmark
ADMIRE-HF trial10 included 961 pts with
LVEF B 35% and NYHA class II or III and assessed
the relationship between scintigraphic measures of
cardiac denervation and HF progression, arrhythmic
events, and cardiac death. A late HMR higher than 1.60
was associated with a hazard ratio of 0.49, 0.37, and
0.14, respectively. A subanalysis of the trial reinforced
the prognostic value regarding arrhythmic events.38
123I-mIBG scintigraphy has also been employed in
the assessment of pts submitted to CRT. Data from
several groups report an association between cardiac
denervation and response to CRT.19,21,22 In similarity,
we also found that late HMR predicted echocardio-
graphic response to CRT.
Response to CRT is determined by the interaction
of a number of cofactors besides cardiac denervation,
such as gender, type of cardiomyopathy, sinus rhythm,
QRS morphology and duration, medical comorbidities,
hemodynamic abnormalities, and abnormalities of left
ventricle substrate.39,40 As such, no parameter can solely
account for the ability of one pt to respond to CRT and
this explains the proportion of pts with cardiac dener-
vation and an adequate echocardiographic response
reported our study.
Relationship Between Cardiac Denervation
and Global Longitudinal Strain
Speckle tracking is a recent technique based on 2D
ultrasound acquisition, allowing for the calculation of
segmental and global wall strain, and has been validated
against sonomicrometry and magnetic resonance imag-
ing.41,42 GLS has previously been linked to prognosis both
in ptswith preserved43 and reduced LV ejection fraction.44
We hypothesized that local myocardial deformation
as assessed by 2D longitudinal strain would reflect
regional autonomic activity, and as such GLS could act
as a surrogate for cardiac autonomic dysfunction. The
issue of GLS and its relationship to cardiac denervation
has been previously assessed by Bulten et al, who also
found a significant correlation between GLS and late
HMR in 59 breast cancer pts who had undergone
anthracycline chemotherapy.45 However, these pts
mostly had preserved LVEF (56 out of 59), and mean
late HMR was 2.72 suggesting a low prevalence of
cardiac denervation in this population. Our results
extend this relationship to the spectrum of pts with
reduced left ventricular systolic function and severely
impaired cardiac autonomic function. Curiously, the
magnitude of this correlation was similar between
studies (- 0.23 vs - 0.282), suggesting a consistent
relationship between myocardial deformation and local
autonomic function. This correlation also remained at
follow-up after CRT, further reinforcing the value of
GLS in assessing autonomic function.
We found that the relationship between late HMR
and GLS was consistent throughout our cohort; notwith-
standing, GLS was more accurate in identifying severe
cardiac denervation in pts with an ischemic etiology or
with severely depressed LVEF, two subsets of pts which
have been previously linked to less response to CRT.
GLS may therefore help individualize decision making
in this particular population.
The moderate correlation between GLS and late
HMR46 can be explained by the fact that 123I-mIBG
Table 4. Correlation between baseline echocardiographic parameters and cardiac denervation
N 5 81
Early HMR P values Late HMR P values Washout rate P values
GLS - 0.136 0.225 - 0.282 0.011 0.166 0.139
LVEF - 0.032 0.778 0.038 0.734 - 0.016 0.885
E/A ratio - 0.099 0.466 - 0.025 0.857 - 0.020 0.883
E/e0 ratio 0.043 0.752 0.078 0.566 - 0.056 0.682
TAPSE 0.106 0.373 0.164 0.166 0.041 0.729
GLS, global longitudinal strain; HMR, heart-to-mediastinum ratio; LVEF, left ventricular ejection fraction; TAPSE, tricuspid annular
plane systolic excursion
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cardiac uptake can be influenced by many factors, such as
maintenance of b-blockers during imaging,8 acquisition
and processing conditions, such as type and brand of
collimator, background correction, acquisition duration
and timing, injected dose of 123I-mIBG, energy window
and ROI settings,47,48 pt characteristics, like age and
gender,49–51 and heart disease type and stage (NYHA
class and LVEF).49,52 Even though this precludes these
two variables from being interchangeable, there is a
significant clinical relevance to this association, since
GLS analysis is easily accessible and prevents exposure to
radiation, unlike 123I-mIBG scintigraphy. Furthermore,
the ROC curve analysis supports the hypothesis that GLS
can be used to discriminate pts with severe cardiac
denervation and who will therefore follow a more
complicated clinical course.10
Limitations
As this study was not powered to detect a difference
in major events at follow-up, we cannot establish a
relationship between late HMR or GLS and adverse
events. However, as previously reported, there is ample
published data on the prognostic value of different
scintigraphic parameters of autonomic function, partic-
ularly late HMR.
Estimation of GLS was performed using a brand-
specific algorithm for speckle tracking. Therefore, we
cannot extrapolate our findings for other brands, as mean
calculated GLS values differ significantly between
vendors.24
Despite the finding that the performance of GLS in
predicting cardiac denervation was better in pts with
very severe left ventricular dysfunction, ischemic heart
disease, and female pts and even though this subgroup
analysis was predefined, this study was not formally
powered to detect a significant interaction between
subgroups. However, these findings may be considered
as hypothesis-generating requiring further studies to be
confirmed.
123I-mIBG scintigraphy results are highly dependent
on pt and disease characteristics, medication and acqui-
sition and processing conditions, as previously
explained. This might preclude the extrapolation of this
information to other settings and may need further
confirmation in order for these results to be generalized.
Although SPECT acquisitions were not performed,
these could conceivably lead to a more accurate assess-
ment of regional autonomic function and its relation to
segmental strain analysis. However, available data show
that it is difficult to reconstruct SPECT data when global
123I-mIBG uptake is severely reduced; in addition, this
technique is associated to underestimation of 123I-mIBG
uptake in the inferior and apical wall.53
CONCLUSION
In conclusion, in our population of pts with
advanced HFrEF referred for CRT, GLS was moderately
correlated with the extent of cardiac denervation as
assessed by 123I-mIBG scintigraphy and had a good
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Figure 3. Receiver operating curve of global longitudinal strain for a late heart-to-mediastinum cut-
off value of 1.6. Global longitudinal strain (GLS) showed a good discrimination (area under the
receiver operating curve of 0.721) for a pre-specified late heart-to-mediastinum ratio cut-off value of
1.6. A GLS cut-off value of - 9% maximized the likelihood of correctly classifying a patient as
having severe cardiac denervation (likelihood ratio 2.83).
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denervation. As such, GLS, may allow for a more
readily accessible estimation of the degree of autonomic
dysfunction in advanced HF pts. These findings may
have future implications in the screening of CRT
recipients.
NEW KNOWLEDGE GAINED
HF is a very prevalent clinical entity with a high
hospitalization and mortality rate, characterized by
cardiac AD. The most reliable method to assess cardiac
denervation is 123I-mIBG scintigraphy, which is able to
predict mortality and cardiac events, stratify the risk of
sudden cardiac death and ventricular arrhythmias, and
assess response to medical and device therapy. How-
ever, it is not readily accessible and the need for
radiation exposure precludes its widespread use. GLS
has gained popularity in the assessment of myocardial
contractility and this paper introduces its relationship to
cardiac AD. It could be used to identify pts with severe
cardiac denervation, as it is easy to use and widely
accessible.
Future directions of research are:
(1) To validate the relationship of GLS and scinti-
graphic parameters for other brands of GLS.
(2) To validate the relationship of GLS and scinti-
graphic parameters for other acquisition and
processing conditions of 123I-mIBG scintigraphy.
(3) To investigate the association between cardiac
denervation as assessed by SPECT and GLS.
(4) To detect an association between cardiac denerva-
tion as assessed by GLS and adverse events.
Disclosure
Madalena C. Cruz, Ana Abreu, Guilherme Portugal,
Helena Santa-Clara, Pedro S. Cunha, Mario M. Oliveira,
Vanessa Santos, Luı´s Oliveira, Pedro Rio, Ineˆs Rodrigues, Luı´s
A. Morais, Rui C. Ferreira, and Miguel. M. Carmo have no
conflicts of interest to declare.
References
1. Roger V. Epidemiology of heart failure. Circ Res 2013;113:646-
59.
2. Mosterd A, Hoes AW. Clinical epidemiology of heart failure.
Heart 2007;93:1137-46.
3. Crespo-Leiro MG, Anker SD, Maggioni AP, Coats AJ, Filippatos
G, Ruschitzka F, et al. European Society of Cardiology Heart
Failure Long-Term Registry (ESC-HF-LT): 1-Year follow-up
outcomes and differences across regions. Eur J Heart Fail
2016;18:613-25.
4. Packer M. The neurohormonal hypothesis: A theory to explain the
mechanism of disease progression in heart failure. J Am Coll
Cardiol 1992;20:248-54.
5. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman
WS, Lurie K, et al. Decreased catecholamine sensitivity and beta-
adrenergic-receptor density in failing human hearts. N Engl J Med
1982;307:205-11.
6. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler
MD. Adverse consequences of high sympathetic nervous activity
in the failing human heart. J Am Coll Cardiol 1995;26:1257-63.
7. Patel AD, Iskandrian AE. mIBG imaging. J Nucl Cardiol
2002;9:75-94.
8. Flotats A, Carrio´ I, Agostini D, Le Guludec D, Marcassa C,
Scha¨fers M, et al. Proposal for standardization of 123I-
metaiodobenzylguanidine (mIBG) cardiac sympathetic imaging by
the EANM Cardiovascular Committee and the European Council
of Nuclear Cardiology. Eur J Nucl Med Mol Imaging
2010;37:1802-12.
9. Verberne HJ, Brewster LM, Somsen GA, van Eck-Smit BL.
Prognostic value of myocardial 123I-metaiodobenzylguanidine
(mIBG) parameters in patients with heart failure: A systematic
review. Eur Heart J 2008;29:1147-59.
10. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS,
Lopez VA, et al. Myocardial iodine-123 meta-iodobenzylguani-
dine imaging and cardiac events in heart failure. Results of the
prospective ADMIRE-HF (AdreView Myocardial Imaging for
Risk Evaluation in Heart Failure) study. J Am Coll Cardiol
2010;55:2212-21.
11. Nakata T, Nakajima K, Yamashina S, Yamada T, Momose M,
Kasama S, et al. A pooled analysis of multicenter cohort studies of
123I-mIBG imaging of sympathetic innervation for assessment of
long-term prognosis in heart failure. J Am Coll Cardiol Imaging
2013;6:772-84.
12. Arora R, Ferrick KJ, Nakata T, Kaplan RC, Rozengarten M, Latif
F, et al. I-123 mIBG imaging and heart rate variability analysis to
predict the need for an implantable cardioverter defibrillator. J
Nucl Cardiol 2003;10:121-31.
13. Boogers MJ, Borleffs CJ, Henneman MM, van Bommel RJ, van
Ramshorst J, Boersma E, et al. Cardiac sympathetic denervation
assessed with 123-iodine metaiodobenzylguanidine imaging pre-
dicts ventricular arrhythmias in implantable cardioverter-
defibrillator patients. J Am Coll Cardiol 2010;55:2769-77.
14. Tamaki S, Yamada T, Okuyama Y, Morita T, Sanada S, Tsuka-
moto Y, et al. Cardiac iodine-123 metaiodobenzylguanidine
imaging predicts sudden cardiac death independently of left ven-
tricular ejection fraction in patients with chronic heart failure and
left ventricular systolic dysfunction: Results from a comparative
study with signal-averaged electrocardiogram, heart rate variabil-
ity, and QT dispersion. J Am Coll Cardiol 2009;53:426-35.
15. Kasama S, Toyama T, Hatori T, Sumino H, Kumakura H,
Takayama Y, et al. Evaluation of cardiac sympathetic nerve
activity and left ventricular remodelling in patients with dilated
cardiomyopathy on the treatment containing carvedilol. Eur Heart
J 2007;28:989-95.
16. Takeishi Y, Atsumi H, Fujiwara S, Takahashi K, Tomoike H. ACE
inhibition reduces cardiac iodine-123-mIBG release in heart fail-
ure. J Nucl Med 1997;38:1085-9.
17. Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S,
Suzuki T, et al. Spironolactone improves cardiac sympathetic
nerve activity and symptoms in patients with congestive heart
failure. J Nucl Med 2002;43:1279-85.
18. Kasama S, Toyama T, Sumino H, Nakazawa M, Matsumoto N,
Sato Y, et al. Prognostic value of serial cardiac 123I-mIBG imaging
in patients with stabilized chronic heart failure and reduced left
ventricular ejection fraction. J Nucl Med 2008;49:907-14.
19. Nishioka SA, Martinelli Filho M, Branda˜o SC, Giorgi MC, Vieira
ML, Costa R, et al. Cardiac sympathetic activity pre and post
Journal of Nuclear Cardiology Cruz et al
Relationship of left ventricular global longitudinal strain with cardiac autonomic denervation
resynchronization therapy evaluated by 123I-mIBG myocardial
scintigraphy. J Nucl Cardiol 2007;14:852-9.
20. Burri H, Sunthorn H, Somsen A, Fleury E, Stettler C, Shah D,
et al. Improvement in cardiac sympathetic nerve activity in
responders to resynchronization therapy. Europace 2008;10:374-8.
21. Cha YM, Oh J, Miyazaki C, Hayes DL, Rea RF, Shen WK, et al.
Cardiac resynchronization therapy upregulates cardiac autonomic
control. J Cardiovasc Electrophysiol 2008;19:1045-52.
22. Shinohara T, Takahashi N, Saito S, Okada N, Wakisaka O, Yufu
K, et al. Effect of cardiac resynchronization therapy on cardiac
sympathetic nervous dysfunction and serum C-reactive protein
level. Pacing Clin Electrophysiol 2011;34:1225-30.
23. Tanaka H, Tatsumi K, Fujiwara S, Tsuji T, Kaneko A, Ryo K,
et al. Effect of left ventricular dyssynchrony on cardiac sympa-
thetic activity in heart failure patients with wide QRS duration.
Circ J 2012;76:382-9.
24. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A,
Ernande L, et al. Recommendations for cardiac chamber quan-
tification by echocardiography in adults: An update from the
American Society of Echocardiography and the European Asso-
ciation of Cardiovascular Imaging. J Am Soc Echocardiogr
2015;28:1-39.e14.
25. Bertini M, Ng AC, Antoni ML, Nucifora G, Ewe SH, Auger D,
et al. Global longitudinal strain predicts long-term survival in
patients with chronic ischemic cardiomyopathy. Circ Cardiovasc
Imaging 2012;5:383-91.
26. Sengelov M, Jorgensen PG, Jensen JS, Bruun NE, Olsen FJ, Fritz-
Hansen T, et al. Global longitudinal strain is a superior predictor of
all-cause mortality in heart failure with reduced ejection fraction.
JACC Cardiovasc Imaging 2015;8:1351-9.
27. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, Dokainish H,
Edvardsen T, et al. Recommendations for the evaluation of left
ventricular diastolic function by echocardiography: An update
from the American Society of Echocardiography and the European
Association of Cardiovascular Imaging. J Am Soc Echocardiogr
2016;29:277-314.
28. Stanton T, Leano R, Marwick TH. Prediction of all-cause mor-
tality from global longitudinal speckle strain comparison with
ejection fraction and wall motion scoring. Circ Cardiovasc
Imaging 2009;2:356-64.
29. Rickard J,BaranowskiB,WilsonTangWH,GrimmRA,NiebauerM,
Cantillion D, et al. Echocardiographic predictors of long-term sur-
vival in patients undergoing cardiac resynchronization therapy:What
is the optimal metric? J Cardiovasc Electrophysiol 2017;28:410-5.
30. Veltman CE, Boogers MJ, Meinardi JE, Younis IA, Dibbets-
Schneider P, Van der Wall EE, et al. Reproducibility of planar
123I-meta-iodobenzylguanidine (mIBG) myocardial scintigraphy in
patients with heart failure. Eur J Nucl Med Mol Imaging
2012;39:1599-608.
31. Leimbach WN, Wallin BG, Victor RG, Aylward PE, Sundlo¨f G,
Mark AL. Direct evidence from intraneural recordings for
increased central sympathetic outflow in patients with heart fail-
ure. Circulation 1986;73:913-9.
32. Agostini D, Verberne HJ, Hamon M, Jacobson AF, Manrique A.
Cardiac 123I-mIBG scintigraphy in heart failure. Q J Nucl Med
Mol Imaging 2008;52:369-77.
33. Shibata M, Morita Y, Shimizu T, Takahashi K, Suzuki N. Cardiac
parasympathetic dysfunction concurrent with cardiac sympathetic
denervation in Parkinson’s disease. J Neurol Sci 2009;276:79-83.
34. Spiegel J, Hellwig D, Farmakis G, Jost WH, Samnick S, Fass-
bender K, et al. Myocardial sympathetic degeneration correlates
with clinical phenotype of Parkinson’s disease. Mov Disord
2007;22:1004-8.
35. Rosner B. The intraclass correlation coefficient. In: Fundamentals
of biostatistics. 6th ed. Belmont: Duxbury, Thomson Brooks/Cole;
2006. p. 613-5.
36. Nishisato K, Hashimoto A, Nakata T, Doi T, Yamamoto H,
Nagahara D, et al. Impaired cardiac sympathetic innervation and
myocardial perfusion are related to lethal arrhythmia: Quantifica-
tion of cardiac tracers in patients with ICDs. J Nucl Med
2010;51:1241-9.
37. Nagahara D, Nakata T, Hashimoto A, Wakabayashi T, Kyuma M,
Noda R, et al. Predicting the need for an implantable cardioverter
defibrillator using cardiac metaiodobenzylguanidine activity
together with plasma natriuretic peptide concentration or left
ventricular function. J Nucl Med 2008;49:225-33.
38. Al Badarin FJ, Wimmer AP, Kennedy KF, Jacobson AF, Bateman
TM. The utility of ADMIRE-HF risk score in predicting serious
arrhythmic events in heart failure patients: Incremental prognostic
benefit of cardiac 123I-mIBG scintigraphy. J Nucl Cardiol
2014;21:756-62.
39. Rickard J, Michtalik H, Sharma R, Berger Z, Iyoha E, Green AR,
et al. Predictors of response to cardiac resynchronization therapy:
A systematic review. Int J Cardiol 2016;225:345-52.
40. Chatterjee NA, Singh JP. Cardiac resynchronization therapy: Past,
present, and future. Heart Fail Clin 2015;11:287-303.
41. Leitman M, Lysyansky P, Sidenko S, Shir V, Peleg E, Binenbaum
M, et al. Two-dimensional strain—A novel software for real-time
quantitative echocardiographic assessment of myocardial function.
J Am Soc Echocardiogr 2004;17:1021-9.
42. Cho GY, Chan J, Leano R, Strudwick M, Marwick TH. Com-
parison of two-dimensional speckle and tissue velocity based
strain and validation with harmonic phase magnetic resonance
imaging. Am J Cardiol 2006;97:1661-6.
43. Ersbøll M, Valeur N, Mogensen UM, Andersen MJ, Møller JE,
Velazquez EJ, et al. Prediction of all-cause mortality and heart
failure admissions from global left ventricular longitudinal strain
in patients with acute myocardial infarction and preserved left
ventricular ejection fraction. J Am Coll Cardiol 2013;61:2365-73.
44. Mignot A, Donal E, Zaroui A, Reant P, Salem A, Hamon C, et al.
Global longitudinal strain as a major predictor of cardiac events in
patients with depressed left ventricular function: A multicenter
study. J Am Soc Echocardiogr 2010;23:1019-24.
45. Bulten BF, Verberne HJ, Bellersen L, Oyen WJ, Sabate´-Llobera
A, Mavinkurve-Groothuis AM, et al. Relationship of promising
methods in the detection of anthracycline-induced cardiotoxicity
in breast cancer patients. Cancer Chemother Pharmacol
2015;76:957-67.
46. Cohen J. The significance of a product moment rs. In: Statistical
power analysis for the behavioral sciences. 2nd ed. Hillsdale:
Lawrence Erlbaum Associates; 1988. p. 75-107.
47. Chen W, Cao Q, Dilsizian V. Variation of heart-to-mediastinal
ratio in (123)I-mIBG cardiac sympathetic imaging: Its affecting
factors and potential corrections. Curr Cardiol Rep 2011;13:132-7.
48. Nakajima K, Okuda K, Yoshimura M, Matsuo S, Wakabayashi H,
Imanishi Y, et al. Multicenter cross-calibration of I-123
metaiodobenzylguanidine heart-to-mediastinum ratios to over-
come camera-collimator variations. J Nucl Cardiol 2014;21:970-8.
49. Verberne HJ, Habraken JB, van Eck-Smit BL, Agostini D,
Jacobson AF. Variations in 123I-metaiodobenzylguanidine (mIBG)
late heart mediastinal ratios in chronic heart failure: A need for
standardisation and validation. Eur J Nucl Med Mol Imaging
2008;35:547-53.
50. Tsuchimochi S, Tamaki N, Tadamura E, Kawamoto M, Fujita T,
Yonekura Y, et al. Age and gender differences in normal
myocardial adrenergic neuronal function evaluated by iodine-123-
mIBG imaging. J Nucl Med 1995;36:969-74.
Cruz et al Journal of Nuclear Cardiology
Relationship of left ventricular global longitudinal strain with cardiac autonomic denervation
51. Sakata K, Shirotani M, Yoshida H, Kurata C. Physiological fluc-
tuation of the human left ventricle sympathetic nervous system
assessed by iodine-123-mIBG. J Nucl Med 1998;39:1667-71.
52. Wakabayashi T, Nakata T, Hashimoto A, Yuda S, Tsuchihashi K,
Travin MI, et al. Assessment of underlying etiology and cardiac
sympathetic innervation to identify patients at high risk of cardiac
death. J Nucl Med 2001;42:1757-67.
53. Stefanelli A, Treglia G, Giordano A. (123)I-mIBG scintigraphy as a
powerful tool to plan an implantable cardioverter defibrillator and
to assess cardiac resynchronization therapy in heart failure
patients. Int J Mol Imaging 2012;2012:690468.
Journal of Nuclear Cardiology Cruz et al
Relationship of left ventricular global longitudinal strain with cardiac autonomic denervation
